ID   MED-MEB-8S
AC   CVCL_M138
SY   MEBMED8S
DR   Cosmic; 2362658
DR   Wikidata; Q54905005
RX   PubMed=15793295;
RX   PubMed=22976800;
CC   Misspelling: MHH-MED-8S; Cosmic=2362658.
DI   NCIt; C129445; Medulloblastoma, non-WNT/non-SHH, group 3
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M137 ! MED-MEB-8A
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 10
//
RX   PubMed=15793295; DOI=10.1016/S0002-9440(10)62335-8;
RA   Hartmann W., Koch A., Brune H., Waha A., Schuller U., Dani I.,
RA   Denkhaus D., Langmann W., Bode U., Wiestler O.D., Schilling K.,
RA   Pietsch T.;
RT   "Insulin-like growth factor II is involved in the proliferation
RT   control of medulloblastoma and its cerebellar precursor cells.";
RL   Am. J. Pathol. 166:1153-1162(2005).
//
RX   PubMed=22976800; DOI=10.1038/bjc.2012.403;
RA   von Bueren A.O., Bacolod M.D., Hagel C., Heinimann K., Fedier A.,
RA   Kordes U., Pietsch T., Koster J., Grotzer M.A., Friedman H.S.,
RA   Marra G., Kool M., Rutkowski S.;
RT   "Mismatch repair deficiency: a temozolomide resistance factor in
RT   medulloblastoma cell lines that is uncommon in primary medulloblastoma
RT   tumours.";
RL   Br. J. Cancer 107:1399-1408(2012).
//